Biography
Dr. Olive received his Ph.D. in medical microbiology from Loyola University Stritch School of Medicine in Chicago. After postdoctoral research at the University of Illinois Medical Center investigating transcriptional control in SV40, he took a position with Pharmacia as a molecular biologist where he began developing the use of DNA probes for microbial diagnostics. In 1984, he was recruited by the World Health Organization as a scientist in the WHO/CDC program to eradicate poliovirus. In 1990 he returned to the United States as the Senior Manager of Assay Integration for GENE-TRAK/Vysis, applying a new nucleic acid amplification technology to the detection of microbial pathogens. He left after five years to help found Third Wave Technologies where his research team invented and developed a new nucleic acid amplification technology, the Invader. He subsequently held the positions as Vice President of Business Development for Applied Spectral Imaging and Vice President of Translational Research for LI-COR Biosciences. At LI-COR, he led the development of near-infrared dyes and contrast agents for image-guided cancer surgery. Currently he is a consultant for several companies in a variety of areas and serves as an Adjunct Professor of Biology at Nebraska Wesleyan University where he is pursuing his interests of developing lytic bacteriophage as potential therapeutic agents for methicillin resistant Staphylococcus aureus and other bacterial pathogens.
Research Interest
Methicillin resistant Staphylococci, passive antibiotic resistance, bacteriophage antimicrobials.
Related Publications
-
Application of Enzymes: As an Emerging Pharmaceutical Research
Short Article: Arch Med Biotechnol 2018, 1:2
DOI:
Sharma M
-
Isolation and Characterization of Starter Culture Bacteria for Ensete Ventricosum Fermentation
Research Article: Arch Med Biotechnol 2018, 1:2
DOI:
Meskerem Elfu
-
Inhibitory Action of Essential Oils on Quorum Sensing Activity of Pseudomonas Aeruginosa by Effecting on Pyocyanin Production
Research Article: Arch Med Biotechnol 2018, 1:2
DOI:
Ali Abdul Hussein S AL Janabi
-
Literature Based Pharmacochemical Information of Caesalpinia pulcherima
Short Communication: Arch Med Biotechnol 2018, 1:2
DOI:
Rashidi Dachi
-
Evaluating the Technical Infrastructure of Electronic Health Record System (SEPAS)
Research Article: Arch Med Biotechnol 2018, 1:2
DOI:
Fharzane Balochzahe Shahbakhsh
-
The Promise of Bacteriophage Antimicrobial Therapeutics
Editorial: Arch Med Biotechnol 2018, 1:1
DOI:
D. Michael Olive and Joseph O’Connor
-
3D Cell Culture to Analyze Tumor Cell Nanovesicles Role in Prostate Cancer Pathogenesis
Research Article: Arch Med Biotechnol 2018, 1:1
DOI:
Faria RO, Moraes DD, Souza AG, Silva IBB and Alonso-Goulart V
-
The Role of Virus Receptor Recognition in the Determination of Pathogenesis
Review Article: Arch Med Biotechnol 2018, 1:1
DOI:
Aliyu Adamu, Aminu HA, Firdausi Aliyu and Mienda BS
-
Animal Model for Glioma: A Brief Overview
Review Article: Arch Med Biotechnol 2018, 1:1
DOI:
Phanithi Prakash Babu and Ravindra Pramod Deshpande
-
Prevalence of Women Taking Iron-Folic Acid (IFA) During Pregnancy and its Impact on Childâs Birth Weight
Research Article: Arch Med Biotechnol 2018, 1:1
DOI:
Deo Sushma, Pandey Shila and Kharel Sushil